Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · IEX Real-Time Price · USD
5.14
-0.12 (-2.28%)
At close: Jul 19, 2024, 4:00 PM
5.21
+0.07 (1.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Applied Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2017
Revenue
-0.489.990000
Upgrade
Gross Profit
-0.489.990000
Upgrade
Selling, General & Admin
24.1120.6227.3243.0532.6813.23
Upgrade
Research & Development
50.1953.9155.6362.5761.7932.35
Upgrade
Operating Expenses
74.374.5382.95105.6294.4745.58
Upgrade
Operating Income
-74.77-64.54-82.95-105.62-94.47-45.58
Upgrade
Interest Expense / Income
00000.560.09
Upgrade
Other Expense / Income
118.7955.23-0.44-0.03-1.06-0.16
Upgrade
Pretax Income
-193.56-119.76-82.51-105.58-93.96-45.51
Upgrade
Net Income
-193.56-119.76-82.51-105.58-93.96-45.51
Upgrade
Shares Outstanding (Basic)
1258438262213
Upgrade
Shares Outstanding (Diluted)
1258438262213
Upgrade
Shares Change
122.36%122.72%47.77%16.53%71.19%134.01%
Upgrade
EPS (Basic)
-1.84-1.42-2.18-4.12-4.28-3.55
Upgrade
EPS (Diluted)
-1.84-1.42-2.18-4.12-4.28-3.55
Upgrade
Free Cash Flow
-67.09-55.17-78.09-90.73-78.21-36.31
Upgrade
Free Cash Flow Per Share
-0.54-0.66-2.06-3.54-3.56-2.83
Upgrade
Gross Margin
-100.00%----
Upgrade
Operating Margin
--645.80%----
Upgrade
Profit Margin
--1198.47%----
Upgrade
Free Cash Flow Margin
--552.12%----
Upgrade
EBITDA
-193.21-119.41-82.07-105.17-93.02-45.4
Upgrade
EBITDA Margin
--1194.94%----
Upgrade
Depreciation & Amortization
0.360.350.440.420.380.02
Upgrade
EBIT
-193.56-119.76-82.51-105.58-93.4-45.42
Upgrade
EBIT Margin
--1198.47%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).